"Our program in the Washington, D.C. area is the longest running kidney transplant program and one of the largest transplant centers in the region, providing premier liver disease and liver failure care. Call to schedule your evaluation today."

During the past decade, MedStar Georgetown Transplant Institute conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 1 clinical trials were completed, i.e. on average, 10% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "MedStar Georgetown Transplant Institute" #1 sponsor was "Georgetown University" with 2 trials, followed by "Johns Hopkins University" with 2 trials sponsored, "Northwestern University" with 2 trials sponsored, "Hansa Biopharma AB" with 1 trials sponsored and "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "MedStar Georgetown Transplant Institute" #1 collaborator was "Georgetown University" with 2 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials as a collaborator and "Clinical Trials in Organ Transplantation in Children" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "MedStar Georgetown Transplant Institute" are "Chronic Kidney Diseases" (2 trials), "Hiv" (2 trials), "Apolipoprotein L1" (1 trials), "Cholestasis of Parenteral Nutrition" (1 trials) and "Delayed Graft Function" (1 trials). Many other conditions were trialed in "MedStar Georgetown Transplant Institute" in a lesser frequency.

Most popular intervention types in "MedStar Georgetown Transplant Institute" are "Drug" (6 trials), "Other" (5 trials), "Behavioral" (2 trials), "Procedure" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "APOL1 Counseling Training Program" (1 trials), "APOL1 genetic testing" (1 trials), "Acthar" (1 trials), "Anti-CD20 antibodies" (1 trials) and "Components of Genetic Counseling" (1 trials). Other intervention names were less common.

The vast majority of trials in "MedStar Georgetown Transplant Institute" are 11 trials for "All" genders.

Currently, there are NaN active trials in "MedStar Georgetown Transplant Institute". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 2 completed trials in MedStar Georgetown Transplant Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in MedStar Georgetown Transplant Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".

MedStar Georgetown Transplant Institute has several departments that took part in Clinical trials: "Washington Cancer Institute" - 89 trials, "Medstar Heart and Vascular Institute" - 7 trials